Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Nigeria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Nigeria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Nigeria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape in Nigeria, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Pfizer, May & Baker, Novartis and Fidson) and profile and SWOT analyses of the major player in the medical device market (Roche Diagnostics)
- Porter’s five forces analysis for pharmaceutical and medical devices market of Nigeria
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Nigerian healthcare market.
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Nigerian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Nigerian healthcare market.
'
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Market Access, Pricing of Medicines, Nigeria, 2018 50
Table 2: Market Access, Summary of registration processes with timelines, Nigeria, 2018 52
List of Figures
Figure 1: Pharmaceutical Market, Nigeria, Revenue ($bn), 2010-2017 6
Figure 2: Medical Device Market, Nigeria, Revenue ($m), 2013-2017 6
Figure 3: Country Profile, Nigeria, 2018 10
Figure 4: Pharmaceutical Market, Nigeria, Revenue ($bn), 2010-2017 12
Figure 5: Pharmaceutical Market, Nigeria, Revenue forecast ($bn), 2018-2022 12
Figure 6: Pharmaceutical Exports ($m), Nigeria, 2010-2017 13
Figure 7: Top Export Partners, Nigeria, 2017 13
Figure 8: Pharmaceutical Imports ($m), Nigeria, 2010-2017 14
Figure 9: Top Import Partners, Nigeria, 2017 14
Figure 10: Distribution Channels, Nigeria 15
Figure 11: Pharmaceutical Market, Nigeria, Major Players 18
Figure 12: Medical Device Market, Nigeria, Revenue ($m), 2013-2017 33
Figure 13: Overview of Public Healthcare System, Nigeria, 2018 45
Figure 14: NHIS Programmes, Nigeria, 2018 48
Figure 15: Out-of-Pocket Expenditure (% of total expenditure on health), Nigeria, 2010-2017 49
Figure 16: Change in Price Trend in Healthcare Sector (%), Nigeria, 2010-2017 49
Figure 17: NAFDAC, Organizational Structure, Nigeria, 2018 51
Figure 18: Market Authorization Procedure, Nigeria, 2018 52
Figure 19: New Medical Approval Process, Nigeria, 2018 53
Figure 20: Patent Approval Process, Nigeria, 2018 56
Figure 21: Trademark Approval Process, Nigeria, 2018 57
Figure 22: Clinical Trial Regulation Process, Nigeria, 2018 58
Figure 23: Labelling and Packaging Regulations, Nigeria, 2018 61
Figure 24: Life Expectancy (years), Nigeria, 2010-2017 64
Figure 25: Immunization Rate (%), Nigeria, 2010-2017 64
Figure 26: Major Causes of Mortality, No. of deaths (‘000), Nigeria, 2012 65
Figure 27: Major Causes of Male Mortality, No. of deaths (‘000), Nigeria, 2016 65
Figure 28: Major Causes of Female Mortality, No. of deaths (‘000), Nigeria, 2016 65
Figure 29: Disability-Adjusted Life Years by Major Disease (‘000), Nigeria, 2015 65
Figure 30: Health Care Personnel (per 1,000 population), Nigeria, 2009-2011 66
Figure 31: PM2.5 (μg per m3), Nigeria, 2010-2017 67
Figure 32: CO2 Emissions (k tons), Nigeria, 2010-2017 67
Figure 33: Healthcare Expenditure (% of GDP ), Nigeria, 2010-2017 68
Figure 34: Public-Private Share (%), Nigeria, 2010-2017 68
Figure 35: Trade Associations, Nigeria 69
Figure 36: Opportunities and Challenges, Nigeria 71
